Текст книги "А мне помогло. Как ориентироваться в море информации о здоровье и осознанно принимать решения"

30. Zang EA, Wynder EL. Reevaluation of the confounding effect of cigarette smoking on the relationship between alcohol use and lung cancer risk, with larynx cancer used as a positive control. Prev Med. 2001 Apr;32(4):359–70. doi: 10.1006/pmed.2000.0818. PMID: 11304097.

ГЛАВА 6

1. Pollard, A.J., Bijker, E.M. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 21, 83–100 (2021). https://doi.org/10.1038/s41577–020–00479–7

2. Stamatakis E, Owen KB, Shepherd L, Drayton B, Hamer M, Bauman AE. Is Cohort Representativeness Passé? Poststratified Associations of Lifestyle Risk Factors with Mortality in the UK Biobank. Epidemiology. 2021 Mar 1;32(2):179–188. doi: 10.1097/EDE.0000000000001316. PMID: 33492009; PMCID: PMC7850587.

3. Bennett et al. “Neural Correlates of Interspecies Perspective Taking in the Post-Mortem Atlantic Salmon: An Argument For Proper Multiple Comparisons Correction” Journal of Serendipitous and Unexpected Results, 2010.

4. https://blogs.scientificamerican.com/scicurious-brain/ignobel-prize-in-neuroscience-the-dead-salmon-study/

5. https://boingboing.net/2012/10/02/what-a-dead-fish-can-teach-you.html

6. Shoda, Y., Mischel, W., & Peake, P. K. (1990). Predicting adolescent cognitive and self-regulatory competencies from preschool delay of gratification: Identifying diagnostic conditions. Developmental Psychology, 26(6), 978–986. doi:10.1037/0012–1649.26.6.978

7. Watts, T. W., Duncan, G. J., & Quan, H. (2018). Revisiting the Marshmallow Test: A Conceptual Replication Investigating Links Between Early Delay of Gratification and Later Outcomes. Psychological Science, 29(7), 1159–1177. doi:10.1177/0956797618761661

8. Miguel A. Herna´n, a Alvaro Alonso, b and Giancarlo Logroscinoa. Cigarette Smoking and Dementia. Potential Selection Bias in the Elderly. Epidemiology 2008;19: 448–450 https://www.hsph.harvard.edu/wp-content/uploads/sites/1268/2014/11/Cigarette_Smoking_and_Dementia__Potential.17.pdf

9. Katzman, R., Aronson, M., Fuld, P., Kawas, C., Brown, T., Morgenstern, H., … Ooi, W. L. (1989). Development of dementing illnesses in an 80‐year-old volunteer cohort. Annals of Neurology, 25(4), 317–324. doi:10.1002/ana.410250402

10. Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., & Breteler, M. M. B. (2007). Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study. Neurology, 69(10), 998–1005. doi:10.1212/01.wnl.0000271395.296

11. Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y (2015) Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers. PLoS ONE 10(3): e0118333. https://doi.org/10.1371/journal.pone.0118333

12. Heliövaara M, Aho K, Knekt P, Impivaara O, Reunanen A, Aromaa A. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis. 2000 Aug;59(8):631–5. doi: 10.1136/ard.59.8.631. PMID: 10913061; PMCID: PMC1753204.

13. Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, Cerhan JR. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women’s Health Study. Ann Rheum Dis. 2002 Nov;61(11):994–9. doi: 10.1136/ard.61.11.994. PMID: 12379522; PMCID: PMC1753931.

14. Karlson EW, Mandl LA, Aweh GN, Grodstein F. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum. 2003 Nov;48(11):3055–60. doi: 10.1002/art.11306. PMID: 14613266.

15. Перл Джуда, Маккензи Дана: Думай «почему?». Причина и следствие как ключ к мышлению Подробнее: https://www.labirint.ru/books/912207/

16. Hui M, Doherty M, Zhang W. Does smoking protect against osteoarthritis? Meta-analysis of observational studies. Ann Rheum Dis. 2011 Jul;70(7):1231–7. doi: 10.1136/ard.2010.142323. Epub 2011 Apr 7. PMID: 21474488.

17. https://www.bbc.com/news/magazine‐27537142

18. Mischel W, Ebbesen EB, Zeiss AR. Cognitive and attentional mechanisms in delay of gratification. J Pers Soc Psychol. 1972 Feb;21(2):204–18. doi: 10.1037/h0032198. PMID: 5010404.

19. Kidd C, Palmeri H, Aslin RN. Rational snacking: young children’s decision-making on the marshmallow task is moderated by beliefs about environmental reliability. Cognition. 2013 Jan;126(1):109–14. doi: 10.1016/j.cognition.2012.08.004. Epub 2012 Oct 9. PMID: 23063236; PMCID: PMC3730121.

20. Lawson, D.J., Davies, N.M., Haworth, S. et al. Is population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?. Hum Genet 139, 23–41 (2020). https://doi.org/10.1007/s00439–019–02014–8

21. «Розовый мозг, голубой мозг» автора Лиза Элиот

22. Eliot L, Ahmed A, Khan H, Patel J. Dump the “dimorphism”: Comprehensive synthesis of human brain studies reveals few male-female differences beyond size. Neurosci Biobehav Rev. 2021 Jun;125:667–697. doi: 10.1016/j.neubiorev.2021.02.026. Epub 2021 Feb 20. PMID: 33621637.

23. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. Ten‐year follow‐up from the nurses’ health study. N Engl J Med. 1991; 325: 756–762.

24. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol. 2005; 162: 404–414.

25. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002 Aug 20;137(4):273–84. doi: 10.7326/0003–4819–137–4–200208200–00012. PMID: 12186518.

26. Meir J Stampfer, Graham A Colditz, Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence, International Journal of Epidemiology, Volume 33, Issue 3, June 2004, Pages 445–453, https://doi.org/10.1093/ije/dyh125

27. Button, K., Ioannidis, J., Mokrysz, C. et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14, 365–376 (2013). https://doi.org/10.1038/nrn3475

28. Cohen, J. The statistical power of abnormal-social psychological research: a review. J. Abnorm. Soc. Psychol. 65, 145–153 (1962).

29. Baker, M. 1,500 scientists lift the lid on reproducibility. Nature 533, 452–454 (2016). https://doi.org/10.1038/533452a

30. Matthews, R. (2000), Storks Deliver Babies (p= 0.008). Teaching Statistics, 22: 36–38. https://doi.org/10.1111/1467–9639.00013

31. BERKSON J. Limitations of the application of fourfold table analysis to hospital data. Biometrics. 1946 Jun;2(3):47–53. PMID: 21001024.

32. Catalogue of Bias Collaboration. Spencer EA, Aronson JK, Nunan D, Heneghan C. Berkson’s bias. In: Catalogue Of Bias 2018: www.catalogueofbiases.org/biases/admission-rate-berkson-bias

33. PottegÃ¥rd A, Lund L C, Karlstad /span>, Dahl J, Andersen M, Hallas J et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study BMJ 2021; 373: n1114 doi:10.1136/bmj.n1114

34. Sex Differences in the Functional Organization of the Brain for Language. Bennett A. Shaywitz, Sally E. Shaywitz, Kenneth R. Pugh, R. Todd Constable, Pawel Skudlarski, Robert K. Fulbright, Richard A. Bronen, Jack M. Fletcher, Donald P. Shankweiler, Leonard Katz and John C. Gore in Nature, Vol. 373, pages 607–609; February 16, 1995

35. https://www.nytimes.com/2018/09/21/health/dyslexia-shaywitz-yale.html The Couple Who Helped Decode Dyslexia

36. Top 1 °Countries that Drink the Most Coffee Per Person (kg/lbs per year) (International Coffee Organization 2016) https://worldpopulationreview.com/country-rankings/coffee-consumption-by-country

37. Reep-van den Bergh CMM, Harteloh PPM, Croes EA. Doodsoorzaak nr. 1 bij jonge Nederlanders: de sigaret [Leading cause of death in young Dutch people: the cigarette]. Ned Tijdschr Geneeskd. 2017;161: D1991. Dutch. PMID: 28914220.

ГЛАВА 7

1. Автор: Шанский Николай Максимович. Год: 2007. Оригинальное название: Лингвистические детективы / Н. М. Шанский. – 4‐е изд., стереотип.

2. Вероника Юрченко Врать, ворчать, врачевать «Квантик» № 11, 2013 https://elementy.ru/nauchno-populyarnaya_biblioteka/432480/Vrat_vorchat_vrachevat

3. McGough JJ, Faraone SV. Estimating the size of treatment effects: moving beyond p values. Psychiatry (Edgmont). 2009 Oct;6(10):21–9. PMID: 20011465; PMCID: PMC2791668. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791668/

4. Ramsden C E, Zamora D, Faurot K R, MacIntosh B, Horowitz M, Keyes G S et al. Dietary alteration of n‐3 and n‐6 fatty acids for headache reduction in adults with migraine: randomized controlled trial BMJ 2021; 374: n1448 doi:10.1136/bmj.n1448

5. https://www.science.org/content/blog-post/up-speed-meldonium

6. https://blogs.bmj.com/bjsm/2016/04/17/the-sharapova-drug-story-whats-the-evidence-does-meldonium-treat-heart-conditions-and-diabetes/

7. Танашян М. М., Максимова М. Ю., Шабалина А. А., Федин П. А., Медведев Р. Б., Болотова Т. А. Журнал: Журнал неврологии и психиатрии им. С. С. Корсакова. Том: 120. Номер: 10. Год издания: 2020. Издательство: Медиа Сфера. Местоположение издательства: М. Первая страница: 14. Последняя страница: 2. DOI: 10.17116/jnevro202012010114

8. Szatmári S, Whitehouse P. Vinpocetine for cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003119. DOI: 10.1002/14651858.CD003119. Accessed 04 October 2023.

9. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960–6. Back to cited text no. 4

10. Forbes DBlinding: an essential component in decreasing risk of bias in experimental designsEvidence-Based Nursing 2013;16:70–71.

11. Emrick, C.D. (1987), Alcoholics Anonymous: Affiliation Processes and Effectiveness as Treatment. Alcoholism: Clinical and Experimental Research, 11: 416–423. https://doi.org/10.1111/j.1530–0277.1987.tb01915.x

12. Walitzer, K.S., Dermen, K.H. and Barrick, C. (2009), Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomized clinical trial. Addiction, 104: 391–401. https://doi.org/10.1111/j.1360–0443.2008.02467.x

13. Bhatt A. Evolution of clinical research: a history before and beyond james lind. Perspect Clin Res. 2010 Jan;1(1):6–10. PMID: 21829774; PMCID: PMC3149409.

14. James Lind and Scurvy: The First Clinical Trial in History? https://www.bbvaopenmind.com/en/science/leading-figures/james-lind-and-scurvy-the-first-clinical-trial-in-history/ (последний доступ 4 октября 2023).

15. Humphreys, K., Blodgett, J.C. and Wagner, T.H. (2014), Estimating the Efficacy of Alcoholics Anonymous without Self-Selection Bias: An Instrumental Variables Re-Analysis of Randomized Clinical Trials. Alcohol Clin Exp Res, 38: 2688–2694. https://doi.org/10.1111/acer.12557

16. Kalra DK. Bridging the Racial Disparity Gap in Lipid-Lowering Therapy. J Am Heart Assoc. 2021 Jan 5;10(1): e019533. doi: 10.1161/JAHA.120.019533. Epub 2020 Dec 16. PMID: 33325243; PMCID: PMC7955462.

17. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical Evidence of Bias: Dimensions of Methodological Quality Associated With Estimates of Treatment Effects in Controlled Trials. JAMA. 1995;273(5):408–412. doi:10.1001/jama.1995.03520290060030

18. Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, Collins R, Sever P; ASCOT Investigators. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017 Jun 24;389(10088):2473–2481. doi: 10.1016/S0140–6736(17)31075–9. Epub 2017 May 2. PMID: 28476288.

19. MacKrill K, Gamble GD, Petrie KJ. The Effect of Television and Print News Stories on the Nocebo Responding Following a Generic Medication Switch. Clin Psychol Eur. 2020 Jun 30;2(2): e2623. doi: 10.32872/cpe.v2i2.2623. PMID: 36397827; PMCID: PMC9645488.

20. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001 Mar 10;357(9258):757–62. doi: 10.1016/s0140–6736(00)04169–6. PMID: 11253970.

21. “Captain Cook and the Scourge of Scurvy” BBC – History. Последний доступ 9 октября 2023 https://www.bbc.co.uk/history/british/empire_seapower/captaincook_scurvy_01.shtml

22. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ 2:769–782. Доступен https://www.jameslindlibrary.org/medical-research-council‐1948b/

23. Balint M. e doctor, the patient and the illness. London: Pitman Medical Publishing Co.; 1957

24. Of the imagination, as a cause and as a cure of disorders of the body: exemplified by fictitious tractors, and epidemical convulsions. Bath: R. Crutwell. https://www.jameslindlibrary.org/haygarth-j‐1800/

25. Nichols JTG. The misuses of drugs in modern practice. Massachusetts Medical Society, Medical Communications. 1893;16:3–46. page 28

26. https://countway.harvard.edu/news/backblog-elisha-perkins-metallic-tractors

27. Shorter E. A brief history of placebos and clinical trials in psychiatry. Can J Psychiatry. 2011 Apr;56(4):193–7. doi: 10.1177/070674371105600402. PMID: 21507275; PMCID: PMC3714297.

28. Zunhammer M, Spisák T, Wager TD, Bingel U; Placebo Imaging Consortium. Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data. Nat Commun. 2021 Mar 2;12(1):1391. doi: 10.1038/s41467–021–21179–3. PMID: 33654105; PMCID: PMC7925520.

29. Motta LS, Gosmann NP, Costa MDA, et alPlacebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysisBMJ Ment Health 2023;26: e300630.

30. Previtali D, Merli G, Di Laura Frattura G, Candrian C, Zaffagnini S, Filardo G. The Long-Lasting Effects of “Placebo Injections” in Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2021 Dec;13(1_suppl):185S‐196S. doi: 10.1177/1947603520906597. Epub 2020 Mar 18. PMID: 32186401; PMCID: PMC8808779.

31. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM, Street RL Jr. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res (Hoboken). 2010 Sep;62(9):1229–36. doi: 10.1002/acr.20225. PMID: 20506122; PMCID: PMC3651275.

32. Kirchhof J, Petrakova L, Brinkhoff A, Benson S, Schmidt J, Unteroberdörster M, Wilde B, Kaptchuk TJ, Witzke O, Schedlowski M. Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4223–4227. doi: 10.1073/pnas.1720548115. Epub 2018 Apr 2. PMID: 29610294; PMCID: PMC5910853.

33. Йоханн Хари. Пункт назначения: счастье. Как путешествие длиною 40 000 миль раскрыло реальные причины депрессии и подарило надежду на полноценную жизнь. https://bombora.ru/book/45079/

34. Evers AWM, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, et al. Implications of placebo and nocebo effects for clinical practice: expert consensus. Psychother Psychosom. 2018;87(4):204–10. https://doi.org/10.1159/000490354.

35. Hafliðadóttir, S.H., Juhl, C.B., Nielsen, S.M. et al. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials 22, 493 (2021). https://doi.org/10.1186/s13063–021–05454–8

36. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), Article 2a. https://doi.org/10.1037/1522–3736.1.1.12a

37. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008 Feb;5(2): e45. doi: 10.1371/journal.pmed.0050045. PMID: 18303940; PMCID: PMC2253608.

38. Zettler M, Basch E, Nabhan C. Surrogate End Points and Patient-Reported Outcomes for Novel Oncology Drugs Approved Between 2011 and 2017. JAMA Oncol. 2019;5(9):1358–1359. doi:10.1001/jamaoncol.2019.1760

39. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594–602. doi: 10.1056/NEJM200105243442106. Erratum in: N Engl J Med 2001 Jul 26;345(4):304. PMID: 11372012.

40. Тихова Галина Петровна Планируем клиническое исследование. Вопрос 2: выбор конечных точек // Регионарная анестезия и лечение острой боли. 2014. № 4. URL: https://cyberleninka.ru/article/n/planiruem-klinicheskoe-issledovanie-vopros‐2‐vybor-konechnyh-tochek (дата обращения: 22.04.2022).

ГЛАВА 8

1. Subbiah, V. The next generation of evidence-based medicine. Nat Med 29, 49–58 (2023). https://doi.org/10.1038/s41591–022–02160‐z

2. https://www.nature.com/articles/s41591–022–02160‐z/figures/1

3. https://biolight.com.ua/blog/kak-zarabotat-dengi-na-biodobavkah-pod-sobstvennoy-torgovoy-markoy

4. https://www.google.com/url?q=https://stepbystepbusiness.com/business-ideas/start-a-supplement-business/&sa=D&source=docs&ust=1697875380830281&usg=AOvVaw3BuzcQvMKfHj7pgCz3TCPl

5. https://www.rbc.ru/own_business/07/12/2018/5c07ec619a7947168ea0dc6b

6. https://foodsupplements.freyrsolutions.com/food-supplements-regulatory-services-in-usa

7. Витамины и БАДы. Фармацевт об их пользе и вреде. Автор: Кристин Гиттер. Бомбора 2020

8. Федеральный закон от 13.03.2006 № 38-ФЗ (ред. от 01.05.2019) «О рекламе»;

9. Li J, Somers VK, Xu H, Lopez-Jimenez F, Covassin N. Trends in Use of Melatonin Supplements Among US Adults, 1999–2018. JAMA. 2022;327(5):483–485. doi:10.1001/jama.2021.23652

10. Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, Koffel E, Khawaja IS, Ouellette J, Butler M, Kane RL, Wilt TJ. Management of Insomnia Disorder. Comparative Effectiveness Review No. 159. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290–2012–00016-I). AHRQ Publication No.15(16)-EHC027– EF. Rockville, MD: Agency for Healthcare Research and Quality. December 2015. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

11. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (February 2017). “Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline”. J Clin Sleep Med. 13 (2): 307–349. doi:10.5664/jcsm.6470. PMC 5263087. PMID 27998379.

12. “Slenyto EPAR”. European Medicines Agency (EMA). Retrieved 31 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

13. Abdelgadir IS, Gordon MA, Akobeng AK (December 2018). “Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis” (PDF). Archives of Disease in Childhood. 103 (12): 1155–1162. doi:10.1136/archdischild‐2017–314181. PMID 29720494. S2CID 19107081.

14. Circadin: EPAR – Product Information ANNEX I – SUMMARY OF PRODUCT CHARACTERISTICS (Report). European Medicines Agency (EMA). 2 February 2021. EMEA/H/C/000695 – IA/0066. As PDF. Archived 31 October 2022 at the Wayback Machine Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

15. Matheson E, Hainer BL (July 2017). “Insomnia: Pharmacologic Therapy”. American Family Physician. 96 (1): 29–35. PMID 28671376.

16. Braam W, Smits MG, Didden R, Korzilius H, Van Geijlswijk IM, Curfs LM (May 2009). “Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis”. Developmental Medicine and Child Neurology (Meta-analysis). 51 (5): 340–9. doi:10.1111/j.1469–8749.2008.03244.x. PMID 19379289. S2CID 35553148.

17. Rossignol DA, Frye RE (September 2011). “Melatonin in autism spectrum disorders: a systematic review and meta-analysis”. Developmental Medicine and Child Neurology (Meta-analysis). 53 (9): 783–792. doi:10.1111/j.1469–8749.2011.03980.x. PMID 21518346. S2CID 9951986.

18. Veatch OJ, Pendergast JS, Allen MJ, Leu RM, Johnson CH, Elsea SH, Malow BA (January 2015). “Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay”. Journal of Autism and Developmental Disorders. 45 (1): 100–10. doi:10.1007/s10803–014–2197–4. PMC 4289108. PMID 25059483.

19. Giannotti F, Cortesi F, Cerquiglini A, Bernabei P (August 2006). “An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism”. Journal of Autism and Developmental Disorders. 36 (6): 741–52. doi:10.1007/s10803–006–0116‐z. PMID 16897403. S2CID 19724241.

20. Bendz LM, Scates AC (January 2010). “Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder”. The Annals of Pharmacotherapy. 44 (1): 185–91. doi:10.1345/aph.1M365. PMID 20028959. S2CID 207263711.

21. Melatonin for jet lagDrug and Therapeutics Bulletin 2020;58:21–24. https://dtb.bmj.com/content/58/2/21.long

22. Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–281.

23. Grigg-Damberger MM, Ianakieva D. Poor quality control of over-the-counter melatonin: what they say is often not what you get. J Clin Sleep Med. 2017;13(2):163–165.

24. LeBlanc ES, Perrin N, Johnson JD, Ballatore A, Hillier T. Over-the-Counter and Compounded Vitamin D: Is Potency What We Expect? JAMA Intern Med. 2013;173(7):585–586. doi:10.1001/jamainternmed.2013.3812

25. Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS (May 2012). “Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults”. Journal of Pineal Research. 52 (4): 437–445. doi:10.1111/j.1600–079X.2011.00958.x. PMC 3682489. PMID 22348451.

26. Mohd Rosli RR, Norhayati MN, Ismail SB. Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: a systematic review and meta-analysis. PeerJ. 2021 Jan 13;9: e10527. doi: 10.7717/peerj.10527. PMID: 33520436; PMCID: PMC7811280.

27. Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, Godolphin PJ, Saborido CM, Zamora J, Khan KS, Thangaratinam S. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol. 2021 Jul;8(7): e503‐e512. doi: 10.1016/S2352–3026(21)00137-X. PMID: 34171281; PMCID: PMC7612251.

28. Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016. https://apps.who.int/iris/bitstream/handle/10665/204761/9789241510196_eng.pdf

29. Абдикаримова Р. К. Анализ распространенности железодефицитной анемии в Казахстане // Вестник АГИУВ. 2011. № 3. URL: https://cyberleninka.ru/article/n/analiz-rasprostranennosti-zhelezodefitsitnoy-anemii-v-kazahstane (дата обращения: 05.04.2023).

30. А.Г. Румянцев, И.Н. Захарова, В.М. Чернов, И.С. Тарасова, А.Л. Заплатников, Н.А. Коровина, Т.Э. Боровик, Н.Г. Звонкова, Е.Б. Мачнева, С.И. Лазарева, Т.М. Васильева. Распространенность железодефицитных состояний и факторы, на нее влияющие. Медицинский совет, № 6, 2015 https://remedium.ru/doctor/therapeutics/detail.php? ID=70233

31. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw Open. 2018;1(6): e183337. doi:10.1001/jamanetworkopen.2018.3337

32. https://www.rbc.ru/own_business/07/12/2018/5c07ec619a7947168ea0dc6b (дата обращения: 23.10.2023).

33. https://www.nytimes.com/2015/02/07/opinion/herbal-supplements-without-herbs.html (дата обращения: 23.10.2023).

34. Törring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Sääf M, Hamberger B. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine – a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996 Aug;81(8):2986–93. doi: 10.1210/jcem.81.8.8768863. PMID: 8768863.

35. https://www.ema.europa.eu/en/medicines/national-registers-authorised-medicines

36. https://www.uspnf.com/

37. https://www.newyorker.com/magazine/2013/07/29/slow-ideas?utm_source=NYR_REG_GATE (дата обращения: 23.10.2023).

38. Combe B, Landewe R, Daien CI, et al2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases 2017;76:948–959.

39. Jeremy Howick, Iain Chalmers, Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, and Hazel Thornton. “The 2011 Oxford CEBM Evidence Levels of Evidence (Introductory Document)”. Oxford Centre for Evidence-Based Medicine. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/levels-of-evidence-introductory-document

40. DiNicolantonio J, O’Keefe JH. Does Fish Oil Reduce the Risk of Cardiovascular Events and Death? Recent Level 1 Evidence Says Yes: PRO: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease. Mo Med. 2021 May-Jun;118(3):214–218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210983/pdf/ms118_p0214.pdf

41. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 https://pubmed.ncbi.nlm.nih.gov/23235689/

42. Printz, Jonathon O. et al. Conflict of Interest in the Assessment of Hyaluronic Acid Injections for Osteoarthritis of the Knee: An Updated Systematic Review. The Journal of Arthroplasty, Volume 28, Issue 8, 30–33.e1

43. Edlow JA, Smith EE, Stead LG, Gronseth G, Messé SR, Jagoda AS, et al. Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med. 2013;61(2):225–43. doi:10.1016/j.annemergmed.2012.11.005.

44. Lenzer J. Why we can’t trust clinical guidelines. BMJ. 2013;346: f3830. doi:10.1136/bmj.f3830.

45. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign. BMJ. 2002;324(7339):723–9. doi:10.1136/bmj.324.7339.723.

46. Robbins BD, Higgins M, Fisher M, Over K. Conflicts of interest in research on antipsychotic treatment of pediatric bipolar disorder, temper dysregulation disorder, and attenuated psychotic symptoms syndrome: exploring the unholy alliance between big pharma and psychiatry. J Psychol Issues Organ Cult. 2011;1(4):32–49. doi:10.1002/jpoc.20039.

47. Mandeville KL, O’Neill S, Brighouse A, Walker A, Yarrow K, Chan K. Academics and competing interests in H1N1 influenza media reporting. J Epidemiol Community Health. 2013;68(3):197–203. doi:10.1136/jech‐2013–203128.

48. https://briandeer.com/mmr/lancet-summary.htm (дата обращения: 23.10.2023).

49. Dunn, A.G., Coiera, E., Mandl, K.D. et al. Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integr Peer Rev 1, 1 (2016). https://doi.org/10.1186/s41073–016–0006–7

50. “Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers was originally published by the National Cancer Institute.” https://www.cancer.gov/types/prostate/research/select-trial-results-qa#5 (дата обращения: 23.10.2023).

51. Lippman SM, Goodman PJ, Klein EA, et al. Designing the selenium and vitamin E cancer prevention trial. JNCI 2005; 97(2):94–102.

52. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. JAMA 2009; 301(1). Published online December 9, 2008. Print edition January 2009.

53. EA Klein, IM Thompson, CM Tangen, et al. Vitamin E and the Risk of Prostate Cancer: Results of The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306(14) 1549–1556.

54. Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, Guallar E, Zhao D, Michos ED. Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7): e004224. doi: 10.1161/CIRCOUTCOMES.117.004224. PMID: 29991644.

55. Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse R, Vieth R, Blanco Mejia S, Viguiliouk E, Nishi S, Sahye-Pudaruth S, Paquette M, Patel D, Mitchell S, Kavanagh M, Tsirakis T, Bachiri L, Maran A, Umatheva N, McKay T, Trinidad G, Bernstein D, Chowdhury A, Correa-Betanzo J, Del Principe G, Hajizadeh A, Jayaraman R, Jenkins A, Jenkins W, Kalaichandran R, Kirupaharan G, Manisekaran P, Qutta T, Shahid R, Silver A, Villegas C, White J, Kendall CWC, Pichika SC, Sievenpiper JL. Supplemental Vitamins and Minerals for CVD Prevention and Treatment. J Am Coll Cardiol. 2018 Jun 5;71(22):2570–2584. doi: 10.1016/j.jacc.2018.04.020. PMID: 29852980.

56. Bouillon, R., Manousaki, D., Rosen, C. et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol 18, 96–110 (2022). https://doi.org/10.1038/s41574–021–00593‐z https://www.nature.com/articles/s41574–021–00593‐z

57. Li, S., Guo, Y., Men, J. et al. The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis. BMC Geriatr 21, 367 (2021). https://doi.org/10.1186/s12877–021–02253–3

58. Markun S, Gravestock I, Jäger L, Rosemann T, Pichierri G, Burgstaller JM. Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression. Nutrients. 2021 Mar 12;13(3):923. doi: 10.3390/nu13030923. PMID: 33809274; PMCID: PMC8000524.